SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 9.75
-0.50 (-4.88%)
Mar 31, 2026, 5:15 PM GMT
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 25.27 million as of April 28, 2026. Its market cap has decreased by -53.60% in one year.
Market Cap
25.27M
Enterprise Value
21.48M
Revenue
4.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.75
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 25.27M, an increase of 60.65%. That is a compound annual growth rate of 5.41%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arecor Therapeutics | 24.92M |
| ImmuPharma | 26.20M |
| Sareum Holdings | 28.99M |
| Poolbeg Pharma | 30.32M |
| Aptamer Group | 19.87M |
| Fusion Antibodies | 16.88M |
| IXICO | 14.99M |
| Genflow Biosciences | 13.39M |